Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s):  XRTX

Healthcare
XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance... see more

TSXV:XRTX - Post Discussion

XORTX Therapeutics Inc > a Scientist & CEO, 1 man CANNOT Master TWO SHIPS !!
View:
Post by SpaceLabs on Nov 09, 2021 10:30am

a Scientist & CEO, 1 man CANNOT Master TWO SHIPS !!

This is Common Sense and not Rocket Science Boiler Room'mates on BB,, who by their AGE predictions are  Gaga!, GooGoo! ,DadaDada ,MaamaaMoomoo, figure it out.

More Dilution today by CEO at 30% discount to NY shareholders while we got a massive 1/12 rollback.
There is no need for further dilution by this Scientist who is a Failed CEO by all means.

Allen CEO  needs to choose his ROLE. I suggest he should join the Scientific Board to advance the Med, let a SEASONED CEO in USA take the LEAD ROLE as CEO of XORTX !
Comment by Anklebiter42 on Nov 09, 2021 2:09pm
Spacelab, still trying to organize the C suite and BODs. Stick to your area of influence.......... fetch that cheeseburger and fries. Hold the relish. I thought you were off buying rat poison coins????
Comment by SpaceLabs on Nov 09, 2021 5:36pm
Newborn Anklebiter42 shows up with his TOE in his mouth. What I said was if we had a SEASONED CEO during this Nasdaq IPO, with his connections on Wall St Investment Firms, a large sum could have been raised over $10/shr. since we have only 13M after 1/12 rollback. Allen D'DoffD has no connections and appointed a RoadRunner Capital Firm to raise in the IPO at 30% discount at $4. This BOD has ...more  
XORTX Therapeutics Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities